These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Drug-resistant coagulase-negative staphylococcal endophthalmitis following dexamethasone intravitreal implant. Mahalingam P; Topiwalla TT; Ganesan G Indian J Ophthalmol; 2017 Jul; 65(7):634-636. PubMed ID: 28724830 [TBL] [Abstract][Full Text] [Related]
6. Man With Vision Loss and Eye Pain. Chen KJ; Chen YP; Sun MH Ann Emerg Med; 2017 Mar; 69(3):e19-e20. PubMed ID: 28231998 [No Abstract] [Full Text] [Related]
7. Recent advancements in diabetic retinopathy treatment from the Diabetic Retinopathy Clinical Research Network. Baker CW; Jiang Y; Stone T Curr Opin Ophthalmol; 2016 May; 27(3):210-6. PubMed ID: 26913740 [TBL] [Abstract][Full Text] [Related]
8. Scanning laser entoptic perimetry for the detection of visual defects associated with diabetic retinopathy. El-Bradey M; Plummer DJ; Uwe-Bartsch D; Freeman WR Br J Ophthalmol; 2006 Jan; 90(1):17-9. PubMed ID: 16361659 [TBL] [Abstract][Full Text] [Related]
9. Assessing the painful, uninflamed eye in primary care. Kuffova L; Forrester JV; Dick A BMJ; 2015 Aug; 351():h3216. PubMed ID: 26242844 [No Abstract] [Full Text] [Related]
10. Severe diabetic retinopathy after cataract surgery. Schatz H; Atienza D; McDonald HR; Johnson RN Am J Ophthalmol; 1994 Mar; 117(3):314-21. PubMed ID: 8129003 [TBL] [Abstract][Full Text] [Related]
11. [Vision-threatening retinopathy in diabetics not referred to an ophthalmologist]. Avila Alcaraz Y; Lima Gómez V Gac Med Mex; 2013; 149(6):624-9. PubMed ID: 24276185 [TBL] [Abstract][Full Text] [Related]
12. Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy. Lucena CR; Ramos Filho JA; Messias AM; Silva JA; Almeida FP; Scott IU; Ribeiro JA; Jorge R Arq Bras Oftalmol; 2013; 76(1):18-20. PubMed ID: 23812521 [TBL] [Abstract][Full Text] [Related]
16. Man With Eye Pain and Decreased Vision. Orton S; Roantree RA; Santikul D; Liu T Ann Emerg Med; 2022 Feb; 79(2):e9-e10. PubMed ID: 35065754 [No Abstract] [Full Text] [Related]
18. Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2. Aiello LP; Vignati L; Sheetz MJ; Zhi X; Girach A; Davis MD; Wolka AM; Shahri N; Milton RC; Retina; 2011 Nov; 31(10):2084-94. PubMed ID: 21862954 [TBL] [Abstract][Full Text] [Related]
19. [Pain and deterioration of vision following previous lens implantation]. Zuche H; Seitz B; Viestenz A Ophthalmologe; 2016 May; 113(5):429-31. PubMed ID: 26631046 [No Abstract] [Full Text] [Related]
20. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA; Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]